Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Mixed Tumor, Malignant × Dermatologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 2368 Lymphoma, T-Cell, Cutaneous 430 Skin Neoplasms 373 Carcinoma, Non-Small-Cell Lung 327 Mycosis Fungoides 299 Neoplasms 283 Keratosis, Actinic 275 Sezary Syndrome 266 Breast Neoplasms 248 Lymphoma, Non-Hodgkin 247 Neoplasm Metastasis 246 Carcinoma, Renal Cell 245 Lymphoma 240 Carcinoma, Basal Cell 233 Lymphoma, Large B-Cell, Diffuse 231 Leukemia, Lymphocytic, Chronic, B-Cell 231 Lymphoma, Follicular 228 Lymphoma, Mantle-Cell 217 Hodgkin Disease 217 Precursor Cell Lymphoblastic Leukemia-Lymphoma 216 Lymphoma, B-Cell, Marginal Zone 215 Uveal Melanoma 208 Burkitt Lymphoma 207 Lymphoma, Large-Cell, Immunoblastic 202 Colorectal Neoplasms 169 Lymphoma, Large-Cell, Anaplastic 167 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 161 Ovarian Neoplasms 160 Squamous Cell Carcinoma of Head and Neck 157 Lung Neoplasms 155

Interventions

Tomography, Optical Coherence 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02851693 2019-04-04

OCTSKIN

Centre Hospitalier Universitaire de Saint Etienne

Phase NA Withdrawn

Carcinoma, Keratosis, Mixed Tumor, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon ⚡